Sichuan Hexie Shuangma Co.,Ltd.(000935),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

000935 Sichuan Hexie Shuangma Co.,Ltd.

Closed 12-12 15:00:00

24.43

+0.27

+1.12%

High25.11	Low24.11	Vol17.21M
Open24.11	D1 Closing24.16	Amplitude4.14%
Mkt Cap18.64B	Tradable Cap18.64B	Total Shares763.00M
T/O424.00M	T/O Rate2.26%	Tradable Shares763.00M
P/B2.37	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"000935","market":"SZ","secType":"STK","nameCN":"Sichuan Hexie Shuangma Co.,Ltd.","latestPrice":24.43,"timestamp":1765523007000,"preClose":24.16,"halted":0,"volume":17210408,"delay":0,"changeRate":0.0112,"floatShares":763000000,"shares":763000000,"eps":0.4695,"marketStatus":"Closed","change":0.27,"latestTime":"12-12 15:00:00","open":24.11,"high":25.11,"low":24.11,"amount":424000000,"amplitude":0.0414,"askPrice":24.43,"askSize":991,"bidPrice":24.42,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.4695,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":24.16,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":26.58,"lowLimit":21.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":763440333,"isCdr":false,"pbRate":2.37,"roa":"--","peRate":52.034079,"roe":"3.85%","epsLYR":0.41,"committee":-0.473319,"marketValue":18651000000,"turnoverRate":0.0225,"status":0,"floatMarketCap":18651000000},"requestUrl":"/m/hq/s/000935/tweets","defaultTab":"tweets","newsList":[{"id":"1123075933","title":"Sichuan Hexie Shuangma (000935.SZ) Reports Q1-Q3 Net Profit of 294 Million Yuan, Up 20.03% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1123075933","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123075933?lang=en_us&edition=fundamental","pubTime":"2025-10-30 16:36","pubTimestamp":1761813370,"startTime":"0","endTime":"0","summary":"Sichuan Hexie Shuangma Co.,Ltd. (000935.SZ) released its third-quarter report for 2025. During the first three quarters, the company achieved operating revenue of 917 million yuan, representing a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0235","000935","BK0021","BK0004"],"gpt_icon":0},{"id":"2576382060","title":"Sichuan Hexie Shuangma Gets China Approval for Gonadotropin Suppressant for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2576382060","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576382060?lang=en_us&edition=fundamental","pubTime":"2025-10-17 17:38","pubTimestamp":1760693925,"startTime":"0","endTime":"0","summary":"Chinese state drug authorities approved Sichuan Hexie Shuangma (SHE:000935) subsidiary Hubei Jianxiang Biopharmaceutical's active pharmaceutical ingredient application for leuprorelin acetate, accordi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0004","000935","BK0028","BK0235","BK0021"],"gpt_icon":0},{"id":"1170260896","title":"Sichuan Hexie Shuangma Co., Ltd. (000935.SZ): Approval Granted for Market Launch of Acetate Leuprolide Chemical API","url":"https://stock-news.laohu8.com/highlight/detail?id=1170260896","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170260896?lang=en_us&edition=fundamental","pubTime":"2025-10-16 15:48","pubTimestamp":1760600890,"startTime":"0","endTime":"0","summary":"According to recent announcements, Sichuan Hexie Shuangma Co., Ltd. (000935.SZ) has received approval from the National Medical Products Administration for its subsidiary Hubei Jianxiang...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0004","000935","BK0235","BK0028","BK0021"],"gpt_icon":0},{"id":"2569793441","title":"Sichuan Hexie Shuangma Passes Russian Good Manufacturing Practice Inspection for Diabetes Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2569793441","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569793441?lang=en_us&edition=fundamental","pubTime":"2025-09-23 16:59","pubTimestamp":1758617994,"startTime":"0","endTime":"0","summary":"Sichuan Hexie Shuangma  subsidiary Hubei Jianxiang Biopharmaceutical passed a good manufacturing practice inspection by Russian authorities, according to a Tuesday filing with the Shenzhen bourse.The inspection covered the company's tirzepatide active pharmaceutical ingredient for diabetes treatment, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0004","BK0021","000935","BK0028","BK0235"],"gpt_icon":0},{"id":"2569934207","title":"Hexie Shuangma Unit Secures Russian GMP Certification for Weight Loss Drug Ingredient","url":"https://stock-news.laohu8.com/highlight/detail?id=2569934207","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569934207?lang=en_us&edition=fundamental","pubTime":"2025-09-23 16:58","pubTimestamp":1758617891,"startTime":"0","endTime":"0","summary":"Sichuan Hexie Shuangma  subsidiary Hubei Jianxiang obtained a good manufacturing practice certificate, valid until July 31, 2028, from Russia's industry and trade ministry.The certification follows a successful on-site inspection in late July and early August 2025, covering the production of tirzepatide active pharmaceutical ingredient, according to a Tuesday filing with the Shenzhen bourse.Tirzepatide is used to treat type 2 diabetes and for weight loss.Shares of the company closed 1% lower Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0235","BK0021","BK0028","BK0004","000935"],"gpt_icon":0},{"id":"1154753090","title":"Sichuan Hexie Shuangma Co.,Ltd. (000935.SZ) Subsidiary Hubei Jianxiang Receives Russian GMP Certificate","url":"https://stock-news.laohu8.com/highlight/detail?id=1154753090","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154753090?lang=en_us&edition=fundamental","pubTime":"2025-09-22 16:00","pubTimestamp":1758528016,"startTime":"0","endTime":"0","summary":"Sichuan Hexie Shuangma Co.,Ltd. (000935.SZ) announced that its controlling subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. (\"Hubei Jianxiang\") underwent an on-site inspection by the State Drug...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0004","BK0021","BK0028","000935","BK0235"],"gpt_icon":0},{"id":"1156739742","title":"Sichuan Hexie Shuangma Co.,Ltd. (000935.SZ) Reports Half-Year Results with Net Profit of 129 Million Yuan, Up 13.42% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1156739742","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156739742?lang=en_us&edition=fundamental","pubTime":"2025-08-29 16:26","pubTimestamp":1756455976,"startTime":"0","endTime":"0","summary":"Sichuan Hexie Shuangma Co.,Ltd. (000935.SZ) released its 2025 half-year report. During the reporting period, the company achieved operating revenue of 629 million yuan, representing a year-on-year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0021","000935","BK0004","BK0235","BK0028"],"gpt_icon":0},{"id":"2562739939","title":"BRIEF-SICHUAN HEXIE SHUANGMA's Shareholders To Unload Stakes","url":"https://stock-news.laohu8.com/highlight/detail?id=2562739939","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562739939?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:47","pubTimestamp":1756212423,"startTime":"0","endTime":"0","summary":"BRIEF-SICHUAN HEXIE SHUANGMA's Shareholders To Unload StakesAug 26  - SICHUAN HEXIE SHUANGMA Co Ltd 000935.SZ:SAYS SHAREHOLDERS PLAN TO UNLOAD UP TO COMBINED 2% STAKES IN CO BETWEEN SEPTEMBER 17 AND DECEMBER 15Source textFurther company coverage: 000935.SZ  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nL4N3UI0XR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0235","BK0028","BK0004","000935","BK0021"],"gpt_icon":0},{"id":"2562686739","title":"Sichuan Hexie Shuangma  Says Shareholders Plan to Unload up to Combined 2% Stakes in Co Between September 17 and December 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2562686739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562686739?lang=en_us&edition=fundamental","pubTime":"2025-08-26 20:47","pubTimestamp":1756212423,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nL4N3UI0XR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0021","BK0004","000935","BK0235","BK0028"],"gpt_icon":0},{"id":"2541887240","title":"Hexie Shuangma's Subsidiary Passes US FDA's CGMP Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2541887240","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541887240?lang=en_us&edition=fundamental","pubTime":"2025-06-06 13:46","pubTimestamp":1749188774,"startTime":"0","endTime":"0","summary":"Sichuan Hexie Shuangma's  subsidiary, Hubei Jianxiang Biopharmaceutical, passed the US Food and Drug Administration's current good manufacturing practice on-site inspection, according to a Shenzhen bourse filing on Friday.The inspection, a drug quality assurance inspection, was conducted between March 10 and March 14 in a production line for active pharmaceutical ingredients, such as tirzepatide, semaglutide, liraglutide, and oxytocin.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK0021","BK0235","000935","BK0004"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-08-24","address":"四川省绵阳市江油市二郎庙镇","stockEarnings":[{"period":"1week","weight":0.0226},{"period":"1month","weight":0.1813},{"period":"3month","weight":0.2295},{"period":"6month","weight":0.3618},{"period":"1year","weight":0.4717},{"period":"ytd","weight":0.6872}],"companyName":"四川和谐双马股份有限公司","boardCode":"AI0030","perCapita":"26145股","boardName":"非金属矿物制品业","registeredCapital":"76344万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　四川和谐双马股份有限公司的主营业务是建材生产制造业务、生物医药研发生产业务和私募股权投资基金管理业务。公司的主要产品是水泥、商品熟料、骨料。","serverTime":1765741199726,"listedPrice":4.5,"stockholders":"29200人(较上一季度减少5.50%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sichuan Hexie Shuangma Co.,Ltd.(000935),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sichuan Hexie Shuangma Co.,Ltd.(000935) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sichuan Hexie Shuangma Co.,Ltd.,000935,Sichuan Hexie Shuangma Co.,Ltd.股票,Sichuan Hexie Shuangma Co.,Ltd.股票老虎,Sichuan Hexie Shuangma Co.,Ltd.股票老虎国际,Sichuan Hexie Shuangma Co.,Ltd.行情,Sichuan Hexie Shuangma Co.,Ltd.股票行情,Sichuan Hexie Shuangma Co.,Ltd.股价,Sichuan Hexie Shuangma Co.,Ltd.股市,Sichuan Hexie Shuangma Co.,Ltd.股票价格,Sichuan Hexie Shuangma Co.,Ltd.股票交易,Sichuan Hexie Shuangma Co.,Ltd.股票购买,Sichuan Hexie Shuangma Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sichuan Hexie Shuangma Co.,Ltd.(000935),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sichuan Hexie Shuangma Co.,Ltd.(000935) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction